Two Sigma Advisers’s Genocea Biosciences, Inc. GNCA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q2 | – | Sell |
-10,000
| Closed | -$13K | – | 3008 |
|
|
2022
Q1 | $13K | Sell |
10,000
-12,677
| -56% | -$16.5K | ﹤0.01% | 2688 |
|
|
2021
Q4 | $26K | Sell |
22,677
-119,800
| -84% | -$137K | ﹤0.01% | 2533 |
|
|
2021
Q3 | $274K | Sell |
142,477
-106,000
| -43% | -$204K | ﹤0.01% | 2147 |
|
|
2021
Q2 | $581K | Sell |
248,477
-156,000
| -39% | -$365K | ﹤0.01% | 1876 |
|
|
2021
Q1 | $1.1M | Buy |
404,477
+193,800
| +92% | +$525K | ﹤0.01% | 1607 |
|
|
2020
Q4 | $510K | Buy |
210,677
+136,000
| +182% | +$329K | ﹤0.01% | 1856 |
|
|
2020
Q3 | $171K | Buy |
+74,677
| New | +$171K | ﹤0.01% | 2189 |
|
|
2018
Q3 | – | Sell |
-2,785
| Closed | -$19K | – | 2493 |
|
|
2018
Q2 | $19K | Buy |
2,785
+1,072
| +63% | +$7.31K | ﹤0.01% | 2326 |
|
|
2018
Q1 | $14K | Buy |
+1,713
| New | +$14K | ﹤0.01% | 2282 |
|